Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Opinion & Analysis (TSX:SVA)

    Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

    Stockhouse Editorial February 11, 2021

    Buzz on the Bullboards: When Stocks Go Up … Must They Come Down?

    Stockhouse Editorial January 28, 2021

    Buzz on the Bullboards: A Deeper Look into New Energy Opportunities

    Stockhouse Editorial January 21, 2021

    HemAcure and Sernova, a big deal

    Richard (Rick) Mills July 25, 2017

    Sernova, diabetes and haemophilia

    Rick Rule July 25, 2016

    Sernova (V.SVA) puts focus on diabetes treatment device

    Stockhouse Editorial May 16, 2014

    Canadian Biotech comes back to life: A buyer's guide

    Tony Pullen January 21, 2014

    Progress update on Sernova and N.A. Nickel

    Richard (Rick) Mills July 17, 2012